EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Remyelination of chronic demyelinated lesions with directly induced neural stem cells

Luca Peruzzotti-Jametti, Nunzio Vicario, Giulio Volpe, Sandra Rizzi, Cheek Kwok, Ivan Lombardi, Mads S Bergholt, Lucas Barea-Moya, Andrea D'Angelo, Alexandra M Nicaise, Giuseppe D'Amico, Grzegorz Krzak und 11 weitere

Brain · 03.10.2025 · 148 (10) · 3505-3513

DOI: 10.1093/brain/awaf208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 07.07.2025. Verfasst von Luca Peruzzotti-Jametti und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, Cambridge CB2 0AH, UK. Hauptthemen laut MEDLINE: Neural Stem Cells, Remyelination, Demyelinating Diseases, Stem Cell Transplantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Milano-Bicocca, Medical Research Council, UK Regenerative Medicine Platform.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limited ability of CNS progenitor cells to differentiate into oligodendrocytes limits the repair of demyelinating lesions and contributes to the disability of people with progressive multiple sclerosis (PMS). Neural stem cell (NSC) transplantation has emerged as a safe therapeutic approach in people with PMS, where it holds the promise of healing the injured CNS. However, the mechanisms by which NSC grafts could promote CNS remyelination need to be carefully assessed before their widespread clinical adoption. In this study, we used directly induced NSCs (iNSCs) as a novel transplantation source to boost remyelination in the CNS. Using a mouse model of focal lysophosphatidylcholine (LPC)-induced demyelination, we found that mouse iNSCs promote remyelination by enhancing endogenous oligodendrocyte progenitor cells differentiation and by directly differentiating into mature oligodendrocytes. Transplantation of mouse iNSCs in LPC-lesioned Olig1−/− mice, which exhibits impaired remyelination, confirmed the direct remyelinating ability of grafts and the formation of new exogenous myelin sheaths. We also demonstrated that the xenotransplantation of human iNSCs (hiNSCs) is safe in mice, with hiNSCs persisting long-term in demyelinating lesions where they can produce graft-derived human myelin. Our findings support the use of NSC therapies to enhance remyelination in chronic demyelinating disorders, such as PMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neural Stem CellsRemyelinationDemyelinating DiseasesStem Cell TransplantationAnimalsMiceHumansLysophosphatidylcholinesCell DifferentiationOligodendrogliaMice, Inbred C57BLDisease Models, AnimalMyelin SheathMice, KnockoutMale

Stichwörter der Autor:innen

demyelinationiNSC graftsmultiple sclerosisoligodendrocyte progenitor cellsremyelinationtransplantation

Substanzen

Lysophosphatidylcholines

Autor:innen und Institutionen

  • Department of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, Cambridge CB2 0AH, UK.
  • Department of Biomedical and Biotechnological Sciences, Physiology Section, University of Catania, Catania I-95123, Italy.
  • Institute of Molecular Biology & CMBI, Genomics, Stem Cell Biology & Regenerative Medicine, Leopold-Franzens-University Innsbruck, Innsbruck 6020, Austria.
  • Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg 97070, Germany.
  • Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milano 20126, Italy.
  • Centre for Craniofacial & Regenerative Biology, King's College London, London WC2R 2LS, UK.

ORCID-Profile: Sara Gil-Perotin, Kourosh Saeb-Parsy

Förderung

  • University of Milano-Bicocca
  • Medical Research Council
  • UK Regenerative Medicine Platform
  • Multiple Sclerosis Society
  • Wellcome Trust
  • AISM
  • Italian Ministry of Health
  • Instituto de Salud Carlos III

Zitieren

APA

Peruzzotti-Jametti, L., Vicario, N., Volpe, G., Rizzi, S., Kwok, C., Lombardi, I., Bergholt, M. S., Barea-Moya, L., D'Angelo, A., Nicaise, A. M., D'Amico, G., Krzak, G., Willis, C. M., Gil-Perotin, S., Hruba, O., Braga, A., Stevens, M. M., Garcia-Verdugo, J. M., Saeb-Parsy, K., …, & Pluchino, S. (2025). Remyelination of chronic demyelinated lesions with directly induced neural stem cells. Brain, 148(10), 3505-3513. https://doi.org/10.1093/brain/awaf208

Vancouver

Peruzzotti-Jametti L, Vicario N, Volpe G, Rizzi S, Kwok C, Lombardi I, et al. Remyelination of chronic demyelinated lesions with directly induced neural stem cells. Brain. 2025;148(10):3505-3513. doi:10.1093/brain/awaf208

BibTeX
@article{PeruzzottiJametti2025,
  author = {Peruzzotti-Jametti, Luca and Vicario, Nunzio and Volpe, Giulio and Rizzi, Sandra and Kwok, Cheek and Lombardi, Ivan and Bergholt, Mads S and Barea-Moya, Lucas and D'Angelo, Andrea and Nicaise, Alexandra M and D'Amico, Giuseppe and Krzak, Grzegorz and Willis, Cory M and Gil-Perotin, Sara and Hruba, Olena and Braga, Alice and Stevens, Molly M and Garcia-Verdugo, José M and Saeb-Parsy, Kourosh and Zhao, Chao and Franklin, Robin J M and Edenhofer, Frank and Pluchino, Stefano},
  title = {Remyelination of chronic demyelinated lesions with directly induced neural stem cells},
  journal = {Brain},
  year = {2025},
  volume = {148},
  number = {10},
  pages = {3505--3513},
  doi = {10.1093/brain/awaf208}
}
Kostenlos starten →